BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 54 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,676,000 | -76.6% | 2,599,000 | -76.0% | 0.00% | -66.7% |
| Q2 2018 | $11,433,000 | +8.5% | 10,814,000 | +4.7% | 0.00% | 0.0% |
| Q1 2018 | $10,533,000 | +0.7% | 10,327,000 | +6.8% | 0.00% | 0.0% |
| Q4 2017 | $10,462,000 | +875.0% | 9,670,000 | +905.2% | 0.00% | – |
| Q3 2017 | $1,073,000 | -57.1% | 962,000 | -57.4% | 0.00% | -100.0% |
| Q2 2017 | $2,501,000 | +2532.6% | 2,257,000 | +2586.9% | 0.00% | – |
| Q1 2017 | $95,000 | -97.8% | 84,000 | -97.4% | 0.00% | -100.0% |
| Q3 2015 | $4,223,000 | +215.6% | 3,269,000 | +263.6% | 0.00% | – |
| Q1 2015 | $1,338,000 | -55.2% | 899,000 | -64.6% | 0.00% | -100.0% |
| Q4 2014 | $2,987,000 | +455.2% | 2,541,000 | +400.2% | 0.00% | – |
| Q3 2014 | $538,000 | -43.9% | 508,000 | -41.9% | 0.00% | – |
| Q1 2014 | $959,000 | +13.6% | 875,000 | +9.8% | 0.00% | – |
| Q4 2013 | $844,000 | – | 797,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|